Lantern Pharma Inc (LTRN)
6.305
+0.12
(+1.86%)
USD |
NASDAQ |
May 15, 16:00
6.305
0.00 (0.00%)
After-Hours: 16:27
Lantern Pharma Free Cash Flow: -13.67M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -13.67M |
| December 31, 2023 | -14.37M |
| September 30, 2023 | -13.65M |
| June 30, 2023 | -14.08M |
| March 31, 2023 | -13.23M |
| December 31, 2022 | -12.80M |
| September 30, 2022 | -12.16M |
| June 30, 2022 | -12.80M |
| March 31, 2022 | -11.79M |
| Date | Value |
|---|---|
| December 31, 2021 | -10.61M |
| September 30, 2021 | -10.14M |
| June 30, 2021 | -8.348M |
| March 31, 2021 | -7.109M |
| December 31, 2020 | -5.668M |
| September 30, 2020 | -4.804M |
| June 30, 2020 | -2.466M |
| March 31, 2020 | -2.405M |
| December 31, 2019 | -2.128M |
Free Cash Flow Range, Past 5 Years
-14.37M
Minimum
Dec 2023
-2.128M
Maximum
Dec 2019
-9.568M
Average
-11.20M
Median
Free Cash Flow Benchmarks
| Eyenovia Inc | -27.81M |
| Cassava Sciences Inc | -87.90M |
| Alpine Immune Sciences Inc | -80.96M |
| Clearside Biomedical Inc | -20.49M |
| Poseida Therapeutics Inc | -95.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.068M |
| Cash from Investing (Quarterly) | -0.5562M |
| Cash from Financing (Quarterly) | 0.0547M |
| Free Cash Flow Per Share (Quarterly) | -0.2858 |
| Free Cash Flow Yield | -20.05% |